Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileTheodore Sunki Hong, M.D.

TitleAssociate Professor of Radiation Oncology
InstitutionMassachusetts General Hospital
DepartmentRadiation Oncology
AddressMassachusetts General Hospital
Radiation Oncology
100 Blossom Street
Boston MA 02114
Phone617/643-2651
vCardDownload vCard (login for email)

Collapse Mentoring 
Collapse completed student projects
Long-Term Outcomes and Determination of Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Following Intraoperative Electron Beam Radiation Therapy
Summer, 06/05/12 - 08/15/12

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
U19CA021239     (HONG, THEODORE S)Apr 1, 1997 - Aug 31, 2019
NIH/NCI
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Cong J, Wang Y, Zhang X, Zhang N, Liu L, Soukup K, Michelakos T, Hong T, DeLeo A, Cai L, Sabbatino F, Ferrone S, Lee H, Levina V, Fuchs B, Tanabe K, Lillemoe K, Ferrone C, Wang X. A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiram. Cancer Lett. 2017 Aug 30. PMID: 28864067.
    View in: PubMed
  2. Mihalcik SA, Virani S, Hong TS, Niemierko A, Mino-Kenudson M, Kobayashi WK, Fernández-Del Castillo C, Mamon HJ. Assessment of the Utility of Laparoscopy and Peritoneal Cytology in the Staging of Pancreatic Cancer. Pancreas. 2017 Aug; 46(7):e60-e62. PMID: 28697144.
    View in: PubMed
  3. Kishan AU, Voog JC, Wiseman J, Cook RR, Ancukiewicz M, Lee P, Ryan DP, Clark JW, Berger DL, Cusack JC, Wo JY, Hong TS. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease. Br J Radiol. 2017 Aug; 90(1076):20170134. PMID: 28613934.
    View in: PubMed
  4. Liu H, Naxerova K, Pinter M, Incio J, Lee H, Shigeta K, Ho WW, Crain JA, Jacobson A, Michelakos T, Dias-Santos D, Zanconato A, Hong TS, Clark JW, Murphy JE, Ryan DP, Deshpande V, Lillemoe KD, Fernandez-Del Castillo C, Downes M, Evans RM, Michaelson J, Ferrone CR, Boucher Y, Jain RK. Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma. Clin Cancer Res. 2017 Jun 09. PMID: 28600474.
    View in: PubMed
  5. Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MHG. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2017 Jul 10; 35(20):2324-2328. PMID: 28398845.
    View in: PubMed
  6. Dinaux AM, Amri R, Bordeianou LG, Hong TS, Wo JY, Blaszkowsky LS, Allen JN, Murphy JE, Kunitake H, Berger DL. The Impact of Pathologic Complete Response in Patients with Neoadjuvantly Treated Locally Advanced Rectal Cancer-a Large Single-Center Experience. J Gastrointest Surg. 2017 Jul; 21(7):1153-1158. PMID: 28386670.
    View in: PubMed
  7. Nabavizadeh N, Mitin T, Dawson LA, Hong TS, Thomas CR. Stereotactic body radiotherapy for patients with hepatocellular carcinoma and intermediate grade cirrhosis. Lancet Oncol. 2017 Apr; 18(4):e192. PMID: 28368254.
    View in: PubMed
  8. Rose B, Mitra D, Hong TS, Jee KW, Niemierko A, Drapek LN, Blaszkowsky LS, Allen JN, Murphy JE, Clark JW, Ryan DP, Wo JY. Irradiation of anatomically defined pelvic subsites and acute hematologic toxicity in anal cancer patients undergoing chemoradiation. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):e291-e297. PMID: 28462895.
    View in: PubMed
  9. Hong TS, Allen JN, Shellito PC. Case 39-2016: A Man with a History of Prostate Cancer and Recent Rectal Bleeding. N Engl J Med. 2017 03 02; 376(9):898. PMID: 28273412.
    View in: PubMed
  10. Wang M, Han J, Marcar L, Black J, Liu Q, Li X, Nagulapalli K, Sequist LV, Mak RH, Benes CH, Hong TS, Gurtner K, Krause M, Baumann M, Kang JX, Whetstine JR, Willers H. Radiation Resistance in KRAS-Mutated Lung Cancer Is Enabled by Stem-like Properties Mediated by an Osteopontin-EGFR Pathway. Cancer Res. 2017 Apr 15; 77(8):2018-2028. PMID: 28202526.
    View in: PubMed
  11. Tanguturi SK, Niemierko A, Wo JY, Nguyen KN, Prichard H, Zhu AX, Wolfgang JA, Hong TS. Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose? Pract Radiat Oncol. 2017 Sep - Oct; 7(5):e323-e329. PMID: 28341320.
    View in: PubMed
  12. Mitra D, Hong TS, Horick N, Rose B, Drapek LN, Blaszkowsky LS, Allen JN, Kwak EL, Murphy JE, Clark JW, Ryan DP, Cusack JC, Bordeianou LG, Berger DL, Wo JY. Long-term outcomes and toxicities of a large cohort of anal cancer patients treated with dose-painted IMRT per RTOG 0529. Adv Radiat Oncol. 2017 Apr-Jun; 2(2):110-117. PMID: 28740921.
    View in: PubMed
  13. Nipp RD, Zanconato A, Zheng H, Ferrone CR, Lillemoe KD, Wo JY, Hong TS, Clark JW, Ryan DP, Fernández-Del Castillo C. Predictors of Early Mortality After Surgical Resection of Pancreatic Adenocarcinoma in the Era of Neoadjuvant Treatment. Pancreas. 2017 Feb; 46(2):183-189. PMID: 27846142.
    View in: PubMed
  14. Wo JY, Niemierko A, Ryan DP, Blaszkowsky LS, Clark JW, Kwak EL, Lillemoe KD, Drapek LN, Zhu AX, Allen JN, Faris JE, Murphy JE, Nipp R, Fernandez-Del Castillo C, Ferrone CR, Hong TS. Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer. Am J Clin Oncol. 2017 Jan 27. PMID: 28134673.
    View in: PubMed
  15. Hong TS, Gray PJ, Allen JN, Shellito PC, Lowry KP, Zukerberg LR. Case 39-2016. A 74-Year-Old Man with Rectal Bleeding and a History of Prostate Cancer. N Engl J Med. 2016 12 22; 375(25):2481-2488. PMID: 28002705.
    View in: PubMed
  16. Abou-Alfa GK, Andersen JB, Chapman W, Choti M, Forbes SJ, Gores GJ, Hong TS, Harding JJ, Vander Heiden MG, Javle M, Kelley RK, Kwong LN, Lowery M, Merrell A, Miyabe K, Rhim A, Saha S, Sia D, Tanasanvimon S, Venook A, Valle JW, Walesky C, Whetstine J, Willenbring H, Zhu AX, Mayer D, Stanger BZ. Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol. 2016 Dec; 7(6):819-827. PMID: 28078106.
    View in: PubMed
  17. Kwak EL, Hong TS, Forcione DG, Kambadakone A, Lennerz JK. Case 35-2016. A 62-Year-Old Man with Dysphagia. N Engl J Med. 2016 11 17; 375(20):1983-1991. PMID: 27959609.
    View in: PubMed
  18. Keane FK, Wo JY, Ferrone CR, Clark JW, Blaszkowsky LS, Allen JN, Kwak EL, Ryan DP, Lillemoe KD, Fernandez-Del Castillo C, Hong TS. Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma. Am J Clin Oncol. 2016 Oct 12. PMID: 27740973.
    View in: PubMed
  19. Ryan DP, Hong TS. Understanding the Paradigm Shift in Pancreatic Cancer. J Oncol Pract. 2016 Oct; 12(10):926-927. PMID: 27858558.
    View in: PubMed
  20. Mullen JT, Kwak EL, Hong TS. What's the Best Way to Treat GE Junction Tumors? Approach Like Gastric Cancer. Ann Surg Oncol. 2016 Nov; 23(12):3780-3785. PMID: 27459983.
    View in: PubMed
  21. Perko Z, Bortfeld T, Hong T, Wolfgang J, Unkelbach J. SU-D-204-02: BED Consistent Extrapolation of Mean Dose Tolerances. Med Phys. 2016 Jun; 43(6):3332. PMID: 28047100.
    View in: PubMed
  22. Unkelbach J, Perko Z, Wolfgang J, Hong T. TU-H-BRC-02: Biological Dose Escalation for Liver SBRT Through Spatiotemporal Fractionation. Med Phys. 2016 Jun; 43(6):3766. PMID: 28047290.
    View in: PubMed
  23. Schoenfeld JD, Wo JY, Mamon HJ, Kwak EL, Mullen JT, Enzinger PZ, Blaskowsky LS, Ryan DP, Hong TS. The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation. Am J Clin Oncol. 2016 Jun; 39(3):243-7. PMID: 24577163.
    View in: PubMed
  24. Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, Mohile SG, Mumber M, Schulick R, Shapiro M, Urba S, Zeh HJ, Katz MH. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 Jul 20; 34(21):2541-56. PMID: 27247221.
    View in: PubMed
  25. Keane FK, Wo JY, Zhu AX, Hong TS. Liver-Directed Radiotherapy for Hepatocellular Carcinoma. Liver Cancer. 2016 Jul; 5(3):198-209. PMID: 27493895; PMCID: PMC4960357.
  26. Suker M, Beumer BR, Sadot E, Marthey L, Faris JE, Mellon EA, El-Rayes BF, Wang-Gillam A, Lacy J, Hosein PJ, Moorcraft SY, Conroy T, Hohla F, Allen P, Taieb J, Hong TS, Shridhar R, Chau I, van Eijck CH, Koerkamp BG. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis. Lancet Oncol. 2016 Jun; 17(6):801-810. PMID: 27160474.
    View in: PubMed
  27. Patel SA, Ryan DP, Hong TS. Combined Modality Therapy for Rectal Cancer. Cancer J. 2016 May-Jun; 22(3):211-7. PMID: 27341601.
    View in: PubMed
  28. Setia N, Agoston AT, Han HS, Mullen JT, Duda DG, Clark JW, Deshpande V, Mino-Kenudson M, Srivastava A, Lennerz JK, Hong TS, Kwak EL, Lauwers GY. A protein and mRNA expression-based classification of gastric cancer. Mod Pathol. 2016 Jul; 29(7):772-84. PMID: 27032689.
    View in: PubMed
  29. Patel SA, Wo JY, Hong TS. Advancing Techniques of Radiation Therapy for Rectal Cancer. Semin Radiat Oncol. 2016 Jul; 26(3):220-5. PMID: 27238474.
    View in: PubMed
  30. Muralidhar V, Nipp RD, Ryan DP, Hong TS, Nguyen PL, Wo JY. Association Between Very Small Tumor Size and Increased Cancer-Specific Mortality in Node-Positive Colon Cancer. Dis Colon Rectum. 2016 Mar; 59(3):187-93. PMID: 26855392.
    View in: PubMed
  31. Kamran SC, Hong TS, Wo JY. Advances in the Management of Gastric and Gastroesophageal Cancers. Curr Oncol Rep. 2016 Feb; 18(2):13. PMID: 26769118.
    View in: PubMed
  32. Liu Q, Underwood TS, Kung J, Wang M, Lu HM, Paganetti H, Held KD, Hong TS, Efstathiou JA, Willers H. Disruption of SLX4-MUS81 Function Increases the Relative Biological Effectiveness of Proton Radiation. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):78-85. PMID: 27084631; PMCID: PMC4889010 [Available on 05/01/17].
  33. Fuentes E, Ahmad R, Hong TS, Clark JW, Kwak EL, Rattner DW, Mullen JT. The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality. J Surg Oncol. 2016 Apr; 113(5):560-4. PMID: 26792144.
    View in: PubMed
  34. Rose BS, Jee KW, Niemierko A, Murphy JE, Blaszkowsky LS, Allen JN, Lee LK, Wang Y, Drapek LC, Hong TS, Wo JY. Irradiation of FDG-PET-Defined Active Bone Marrow Subregions and Acute Hematologic Toxicity in Anal Cancer Patients Undergoing Chemoradiation. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):747-54. PMID: 26972647.
    View in: PubMed
  35. Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Goyal L, Murphy JE, Javle MM, Wolfgang JA, Drapek LC, Arellano RS, Mamon HJ, Mullen JT, Yoon SS, Tanabe KK, Ferrone CR, Ryan DP, DeLaney TF, Crane CH, Zhu AX. Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. J Clin Oncol. 2016 Feb 10; 34(5):460-8. PMID: 26668346; PMCID: PMC4872014 [Available on 10/10/16].
  36. Russo M, Siravegna G, Blaszkowsky LS, Corti G, Crisafulli G, Ahronian LG, Mussolin B, Kwak EL, Buscarino M, Lazzari L, Valtorta E, Truini M, Jessop NA, Robinson HE, Hong TS, Mino-Kenudson M, Di Nicolantonio F, Thabet A, Sartore-Bianchi A, Siena S, Iafrate AJ, Bardelli A, Corcoran RB. Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer. Cancer Discov. 2016 Feb; 6(2):147-153. PMID: 26644315; PMCID: PMC4744519.
  37. Keane FK, Hong TS. Charged particle therapy for hepatocellular carcinoma: a commentary on a recently published meta-analysis. Ann Transl Med. 2015 Dec; 3(22):365. PMID: 26807420; PMCID: PMC4701515.
  38. Ferreiro-Neira I, Torres NE, Liesenfeld LF, Chan CH, Penson T, Landesman Y, Senapedis W, Shacham S, Hong TS, Cusack JC. XPO1 Inhibition Enhances Radiation Response in Preclinical Models of Rectal Cancer. Clin Cancer Res. 2016 Apr 01; 22(7):1663-73. PMID: 26603256.
    View in: PubMed
  39. Goodman KA, Patton CE, Fisher GA, Hoffe SE, Haddock MG, Parikh PJ, Kim J, Baxter NN, Czito BG, Hong TS, Herman JM, Crane CH, Hoffman KE. Appropriate customization of radiation therapy for stage II and III rectal cancer: Executive summary of an ASTRO Clinical Practice Statement using the RAND/UCLA Appropriateness Method. Pract Radiat Oncol. 2016 May-Jun; 6(3):166-75. PMID: 26922700.
    View in: PubMed
  40. Tao R, Krishnan S, Bhosale PR, Javle MM, Aloia TA, Shroff RT, Kaseb AO, Bishop AJ, Swanick CW, Koay EJ, Thames HD, Hong TS, Das P, Crane CH. Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis. J Clin Oncol. 2016 Jan 20; 34(3):219-26. PMID: 26503201; PMCID: PMC4980564.
  41. Kwak EL, Ahronian LG, Siravegna G, Mussolin B, Godfrey JT, Clark JW, Blaszkowsky LS, Ryan DP, Lennerz JK, Iafrate AJ, Bardelli A, Hong TS, Corcoran RB. Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer. Cancer Discov. 2015 Dec; 5(12):1271-81. PMID: 26432108; PMCID: PMC4670804 [Available on 06/01/16].
  42. Russo S, Blackstock AW, Herman JM, Abdel-Wahab M, Azad N, Das P, Goodman KA, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer. Am J Clin Oncol. 2015 Oct; 38(5):520-5. PMID: 26371522.
    View in: PubMed
  43. Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT, Lauwers GY. Familial Gastric Cancers. Oncologist. 2015 Dec; 20(12):1365-77. PMID: 26424758; PMCID: PMC4679084 [Available on 12/01/16].
  44. Fuentes E, Ahmad R, Hong TS, Clark JW, Kwak EL, Rattner DW, Mullen JT. Adjuvant Therapy Completion Rates in Patients with Gastric Cancer Undergoing Perioperative Chemotherapy Versus a Surgery-First Approach. J Gastrointest Surg. 2016 Jan; 20(1):172-9; discussion 179. PMID: 26394879.
    View in: PubMed
  45. Ahmad R, Setia N, Schmidt BH, Hong TS, Wo JY, Kwak EL, Rattner DW, Lauwers GY, Mullen JT. Predictors of Lymph Node Metastasis in Western Early Gastric Cancer. J Gastrointest Surg. 2016 Mar; 20(3):531-8. PMID: 26385006.
    View in: PubMed
  46. Sabbatino F, Villani V, Yearley JH, Deshpande V, Cai L, Konstantinidis IT, Moon C, Nota S, Wang Y, Al-Sukaini A, Zhu AX, Goyal L, Ting DT, Bardeesy N, Hong TS, Fernandez-del Castillo C, Tanabe KK, Lillemoe KD, Ferrone S, Ferrone CR. PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma. Clin Cancer Res. 2016 Jan 15; 22(2):470-8. PMID: 26373575.
    View in: PubMed
  47. Niska JR, Keane FK, Wolfgang JA, Hahn PF, Wo JY, Zhu AX, Hong TS. Impact of intravenous contrast enhancement phase on target definition for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (IHC): Observations from patients enrolled on a prospective phase 2 trial. Pract Radiat Oncol. 2016 Jan-Feb; 6(1):e9-16. PMID: 26598907.
    View in: PubMed
  48. Goyal L, Govindan A, Sheth RA, Nardi V, Blaszkowsky LS, Faris JE, Clark JW, Ryan DP, Kwak EL, Allen JN, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Chong DQ, Deshpande V, Borger DR, Iafrate AJ, Bardeesy N, Zheng H, Zhu AX. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma. Oncologist. 2015 Sep; 20(9):1019-27. PMID: 26245674; PMCID: PMC4571807 [Available on 09/01/16].
  49. Daroui P, Jabbour SK, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Hong TS, Jones WE, Kaur H, Konski AA, Koong AC, Kumar R, Pawlik TM, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® Resectable Stomach Cancer. Oncology (Williston Park). 2015 Aug; 29(8):595-602, C3. PMID: 26281845.
    View in: PubMed
  50. Hong TS, Moughan J, Garofalo MC, Bendell J, Berger AC, Oldenburg NB, Anne PR, Perera F, Lee RJ, Jabbour SK, Nowlan A, DeNittis A, Crane C. NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):29-36. PMID: 26163334; PMCID: PMC4540628 [Available on 09/01/16].
  51. He XD, Zhang YB, Wang L, Tian ML, Liu W, Qu Q, Li BL, Hong T, Li NC, Na YQ. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution. Eur J Surg Oncol. 2015 Aug; 41(8):1013-9. PMID: 26005133.
    View in: PubMed
  52. Hong TS, Ryan DP. Adjuvant Chemotherapy for Locally Advanced Rectal Cancer: Is It a Given? J Clin Oncol. 2015 Jun 10; 33(17):1878-80. PMID: 25940719.
    View in: PubMed
  53. Wu AJ, Bosch WR, Chang DT, Hong TS, Jabbour SK, Kleinberg LR, Mamon HJ, Thomas CR, Goodman KA. Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. Int J Radiat Oncol Biol Phys. 2015 Jul 15; 92(4):911-20. PMID: 26104943; PMCID: PMC4481325.
  54. Liu Q, Wang M, Kern AM, Khaled S, Han J, Yeap BY, Hong TS, Settleman J, Benes CH, Held KD, Efstathiou JA, Willers H. Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkers. Mol Cancer Res. 2015 Apr; 13(4):713-20. PMID: 25667133; PMCID: PMC4410013.
  55. Willers H, Hong TS. Towards an integrated understanding of epidermal growth factor receptor biology for radiation therapy: integrins enter. J Natl Cancer Inst. 2015 Feb; 107(2). PMID: 25663686.
    View in: PubMed
  56. Kulkarni NM, Hong TS, Kambadakone A, Arellano RS. CT-guided implantation of intrahepatic fiducial markers for proton beam therapy of liver lesions: assessment of success rate and complications. AJR Am J Roentgenol. 2015 Feb; 204(2):W207-13. PMID: 25615782.
    View in: PubMed
  57. Ferrone CR, Marchegiani G, Hong TS, Ryan DP, Deshpande V, McDonnell EI, Sabbatino F, Santos DD, Allen JN, Blaszkowsky LS, Clark JW, Faris JE, Goyal L, Kwak EL, Murphy JE, Ting DT, Wo JY, Zhu AX, Warshaw AL, Lillemoe KD, Fernández-del Castillo C. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg. 2015 Jan; 261(1):12-7. PMID: 25599322; PMCID: PMC4349683.
  58. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014 Nov 27; 371(22):2140-1. PMID: 25427123.
    View in: PubMed
  59. Mirabeau-Beale K, Hong TS, Niemierko A, Ancukiewicz M, Blaszkowsky LS, Crowley EM, Cusack JC, Drapek LC, Kovalchuk N, Markowski M, Napolitano B, Nyamwanda J, Ryan DP, Wolfgang J, Kachnic LA, Wo JY. Clinical and treatment factors associated with vaginal stenosis after definitive chemoradiation for anal canal cancer. Pract Radiat Oncol. 2015 May-Jun; 5(3):e113-8. PMID: 25424587.
    View in: PubMed
  60. Goodman KA, Milgrom SA, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Hong TS, Jabbour SK, Jones WE, Konski AA, Koong AC, Kumar R, Rodriguez-Bigas M, Small W, Thomas CR, Suh WW. ACR Appropriateness Criteria® rectal cancer: metastatic disease at presentation. Oncology (Williston Park). 2014 Oct; 28(10):867-71, 876, 878. PMID: 25323613.
    View in: PubMed
  61. Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014 Sep 11; 371(11):1039-49. PMID: 25207767.
    View in: PubMed
  62. Hong TS, Bosch WR, Krishnan S, Kim TK, Mamon HJ, Shyn P, Ben-Josef E, Seong J, Haddock MG, Cheng JC, Feng MU, Stephans KL, Roberge D, Crane C, Dawson LA. Interobserver variability in target definition for hepatocellular carcinoma with and without portal vein thrombus: radiation therapy oncology group consensus guidelines. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):804-13. PMID: 24969794; PMCID: PMC4285340.
  63. Tanguturi SK, Wo JY, Zhu AX, Dawson LA, Hong TS. Radiation therapy for liver tumors: ready for inclusion in guidelines? Oncologist. 2014 Aug; 19(8):868-79. PMID: 25001265; PMCID: PMC4122485.
  64. Unkelbach J, Craft D, Hong T, Papp D, Ramakrishnan J, Salari E, Wolfgang J, Bortfeld T. TH-E-BRF-01: Exploiting Tumor Shrinkage in Split-Course Radiotherapy. Med Phys. 2014 Jun; 41(6):569. PMID: 28037976.
    View in: PubMed
  65. Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-del Castillo C, Duda DG. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma. Int J Radiat Oncol Biol Phys. 2014 Jul 15; 89(4):830-8. PMID: 24867540; PMCID: PMC4791180.
  66. Hong TS, Kwak EL. Adjuvant therapy for gastric cancers: more answers or more questions? Ann Surg Oncol. 2014 Oct; 21(11):3367-8. PMID: 24841350.
    View in: PubMed
  67. Unkelbach J, Craft D, Hong T, Papp D, Ramakrishnan J, Salari E, Wolfgang J, Bortfeld T. Exploiting tumor shrinkage through temporal optimization of radiotherapy. Phys Med Biol. 2014 Jun 21; 59(12):3059-79. PMID: 24839901.
    View in: PubMed
  68. Richter JM, Pino MS, Austin TR, Campbell E, Szymonifka J, Russo AL, Hong TS, Borger D, Iafrate AJ, Chung DC. Genetic mechanisms in interval colon cancers. Dig Dis Sci. 2014 Sep; 59(9):2255-63. PMID: 24705641.
    View in: PubMed
  69. Aasi J, Abadie J, Abbott BP, Abbott R, Abbott T, Abernathy MR, Accadia T, Acernese F, Adams C, Adams T, Adhikari RX, Affeldt C, Agathos M, Aggarwal N, Aguiar OD, Ajith P, Allen B, Allocca A, Amador Ceron E, Amariutei D, Anderson RA, Anderson SB, Anderson WG, Arai K, Araya MC, Arceneaux C, Areeda J, Ast S, Aston SM, Astone P, Aufmuth P, Aulbert C, Austin L, Aylott BE, Babak S, Baker PT, Ballardin G, Ballmer SW, Barayoga JC, Barker D, Barnum SH, Barone F, Barr B, Barsotti L, Barsuglia M, Barton MA, Bartos I, Bassiri R, Basti A, Batch J, Bauchrowitz J, Bauer TS, Bebronne M, Behnke B, Bejger M, Beker MG, Bell AS, Bell C, Belopolski I, Bergmann G, Berliner JM, Bersanetti D, Bertolini A, Bessis D, Betzwieser J, Beyersdorf PT, Bhadbhade T, Bilenko IA, Billingsley G, Birch J, Bitossi M, Bizouard MA, Black E, Blackburn JK, Blackburn L, Blair D, Blom M, Bock O, Bodiya TP, Boer M, Bogan C, Bond C, Bondu F, Bonelli L, Bonnand R, Bork R, Born M, Boschi V, Bose S, Bosi L, Bowers J, Bradaschia C, Brady PR, Braginsky VB, Branchesi M, Brannen CA, Brau JE, Breyer J, Briant T, Bridges DO, Brillet A, Brinkmann M, Brisson V, Britzger M, Brooks AF, Brown DA, Brown DD, Brückner F, Bulik T, Bulten HJ, Buonanno A, Buskulic D, Buy C, Byer RL, Cadonati L, Cagnoli G, Calderón Bustillo J, Calloni E, Camp JB, Campsie P, Cannon KC, Canuel B, Cao J, Capano CD, Carbognani F, Carbone L, Caride S, Castiglia A, Caudill S, Cavaglià M, Cavalier F, Cavalieri R, Cella G, Cepeda C, Cesarini E, Chakraborty R, Chalermsongsak T, Chao S, Charlton P, Chassande-Mottin E, Chen X, Chen Y, Chincarini A, Chiummo A, Cho HS, Chow J, Christensen N, Chu Q, Chua SS, Chung S, Ciani G, Clara F, Clark DE, Clark JA, Cleva F, Coccia E, Cohadon PF, Colla A, Colombini M, Constancio M, Conte A, Conte R, Cook D, Corbitt TR, Cordier M, Cornish N, Corsi A, Costa CA, Coughlin MW, Coulon JP, Countryman S, Couvares P, Coward DM, Cowart M, Coyne DC, Craig K, Creighton JD, Creighton TD, Crowder SG, Cumming A, Cunningham L, Cuoco E, Dahl K, Dal Canton T, Damjanic M, Danilishin SL, D'Antonio S, Danzmann K, Dattilo V, Daudert B, Daveloza H, Davier M, Davies GS, Daw EJ, Day R, Dayanga T, De Rosa R, Debreczeni G, Degallaix J, Del Pozzo W, Deleeuw E, Deléglise S, Denker T, Dent T, Dereli H, Dergachev V, DeRosa R, DeSalvo R, Dhurandhar S, Di Fiore L, Di Lieto A, Di Palma I, Di Virgilio A, Díaz M, Dietz A, Dmitry K, Donovan F, Dooley KL, Doravari S, Drago M, Drever RW, Driggers JC, Du Z, Dumas JC, Dwyer S, Eberle T, Edwards M, Effler A, Ehrens P, Eichholz J, Eikenberry SS, Endroczi G, Essick R, Etzel T, Evans K, Evans M, Evans T, Factourovich M, Fafone V, Fairhurst S, Fang Q, Farinon S, Farr B, Farr W, Favata M, Fazi D, Fehrmann H, Feldbaum D, Ferrante I, Ferrini F, Fidecaro F, Finn LS, Fiori I, Fisher R, Flaminio R, Foley E, Foley S, Forsi E, Fotopoulos N, Fournier JD, Franco S, Frasca S, Frasconi F, Frede M, Frei M, Frei Z, Freise A, Frey R, Fricke TT, Fritschel P, Frolov VV, Fujimoto MK, Fulda P, Fyffe M, Gair J, Gammaitoni L, Garcia J, Garufi F, Gehrels N, Gemme G, Genin E, Gennai A, Gergely L, Ghosh S, Giaime JA, Giampanis S, Giardina KD, Giazotto A, Gil-Casanova S, Gill C, Gleason J, Goetz E, Goetz R, Gondan L, González G, Gordon N, Gorodetsky ML, Gossan S, Goßler S, Gouaty R, Graef C, Graff PB, Granata M, Grant A, Gras S, Gray C, Greenhalgh RJ, Gretarsson AM, Griffo C, Groot P, Grote H, Grover K, Grunewald S, Guidi GM, Guido C, Gushwa KE, Gustafson EK, Gustafson R, Hall B, Hall E, Hammer D, Hammond G, Hanke M, Hanks J, Hanna C, Hanson J, Harms J, Harry GM, Harry IW, Harstad ED, Hartman MT, Haughian K, Hayama K, Heefner J, Heidmann A, Heintze M, Heitmann H, Hello P, Hemming G, Hendry M, Heng IS, Heptonstall AW, Heurs M, Hild S, Hoak D, Hodge KA, Holt K, Holtrop M, Hong T, Hooper S, Horrom T, Hosken DJ, Hough J, Howell EJ, Hu Y, Hua Z, Huang V, Huerta EA, Hughey B, Husa S, Huttner SH, Huynh M, Huynh-Dinh T, Iafrate J, Ingram DR, Inta R, Isogai T, Ivanov A, Iyer BR, Izumi K, Jacobson M, et al. Constraints on cosmic strings from the LIGO-Virgo gravitational-wave detectors. Phys Rev Lett. 2014 Apr 04; 112(13):131101. PMID: 24745400.
    View in: PubMed
  70. Chin JY, Pitman MB, Hong TS. Intraductal papillary mucinous neoplasm: clinical surveillance and management decisions. Semin Radiat Oncol. 2014 Apr; 24(2):77-84. PMID: 24635864.
    View in: PubMed
  71. Patel SA, Chen YH, Hornick JL, Catalano P, Nowak JA, Zukerberg LR, Bleday R, Shellito PC, Hong TS, Mamon HJ. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum. 2014 Apr; 57(4):449-59. PMID: 24608301; PMCID: PMC3954982.
  72. Russo AL, Ryan DP, Borger DR, Wo JY, Szymonifka J, Liang WY, Kwak EL, Blaszkowsky LS, Clark JW, Allen JN, Zhu AX, Berger DL, Cusack JC, Mamon HJ, Haigis KM, Hong TS. Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer. J Gastrointest Cancer. 2014 Mar; 45(1):34-9. PMID: 24006244; PMCID: PMC4361942.
  73. Russo AL, Borger DR, Szymonifka J, Ryan DP, Wo JY, Blaszkowsky LS, Kwak EL, Allen JN, Wadlow RC, Zhu AX, Murphy JE, Faris JE, Dias-Santagata D, Haigis KM, Ellisen LW, Iafrate AJ, Hong TS. Mutational analysis and clinical correlation of metastatic colorectal cancer. Cancer. 2014 May 15; 120(10):1482-90. PMID: 24500602; PMCID: PMC4327902.
  74. Borger DR, Goyal L, Yau T, Poon RT, Ancukiewicz M, Deshpande V, Christiani DC, Liebman HM, Yang H, Kim H, Yen K, Faris JE, Iafrate AJ, Kwak EL, Clark JW, Allen JN, Blaszkowsky LS, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Bardeesy N, Straley KS, Agresta S, Schenkein DP, Ellisen LW, Ryan DP, Zhu AX. Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma. Clin Cancer Res. 2014 Apr 01; 20(7):1884-90. PMID: 24478380; PMCID: PMC4107454.
  75. Hong TS, Pretz JL, Herman JM, Abdel-Wahab M, Azad N, Blackstock AW, Das P, Goodman KA, Jabbour SK, Jones WE, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Thomas CR, Zook J, Suh WW. ACR Appropriateness Criteria®-Anal Cancer. Gastrointest Cancer Res. 2014 Jan; 7(1):4-14. PMID: 24558509; PMCID: PMC3924766.
  76. Kim MB, Hong TS, Wo JY. Treatment of stage II-III rectal cancer patients. Curr Oncol Rep. 2014; 16(1):362. PMID: 24323626.
    View in: PubMed
  77. Blaszkowsky LS, Ryan DP, Szymonifka J, Borger DR, Zhu AX, Clark JW, Kwak EL, Mamon HJ, Allen JN, Vasudev E, Shellito PC, Cusack JC, Berger DL, Hong TS. Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer. Ann Oncol. 2014 Jan; 25(1):121-6. PMID: 24356623; PMCID: PMC4271130.
  78. Kleiman LB, Krebs AM, Kim SY, Hong TS, Haigis KM. Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers. PLoS One. 2013; 8(12):e82982. PMID: 24349411; PMCID: PMC3861465.
  79. Wo JY, Dawson LA, Zhu AX, Hong TS. An emerging role for radiation therapy in the treatment of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am. 2014 Apr; 23(2):353-68. PMID: 24560114.
    View in: PubMed
  80. Hong TS, DeLaney TF, Mamon HJ, Willett CG, Yeap BY, Niemierko A, Wolfgang JA, Lu HM, Adams J, Weyman EA, Arellano RS, Blaszkowsky LS, Allen JN, Tanabe KK, Ryan DP, Zhu AX. A prospective feasibility study of respiratory-gated proton beam therapy for liver tumors. Pract Radiat Oncol. 2014 Sep-Oct; 4(5):316-22. PMID: 25194100; PMCID: PMC4327929.
  81. Wo JY, Mamon HJ, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Tseng YD, Napolitano BN, Ancukiewicz M, Swanson RS, Lillemoe KD, Fernandez-del Castillo C, Hong TS. Phase I study of neoadjuvant accelerated short course radiation therapy with photons and capecitabine for resectable pancreatic cancer. Radiother Oncol. 2014 Jan; 110(1):160-4. PMID: 24231241.
    View in: PubMed
  82. Wu S, Sun F, Zhang Y, Yang Z, Hong T, Chen Y, Zhan S. The cardiovascular effects of glucagon-like peptide-1 receptor agonists: a trial sequential analysis of randomized controlled trials. J Clin Pharm Ther. 2014 Feb; 39(1):7-13. PMID: 24127768.
    View in: PubMed
  83. Muir D, Aoina J, Hong T, Mason R. The outcome of the Mobility total ankle replacement at a mean of four years: Can poor outcomes be predicted from pre- and post-operative analysis? Bone Joint J. 2013 Oct; 95-B(10):1366-71. PMID: 24078533.
    View in: PubMed
  84. Cai S, Hong TS, Goldberg SI, Fernandez-del Castillo C, Thayer SP, Ferrone CR, Ryan DP, Blaszkowsky LS, Kwak EL, Willett CG, Lillemoe KD, Warshaw AL, Wo JY. Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. Cancer. 2013 Dec 01; 119(23):4196-204. PMID: 24006012; PMCID: PMC4403862.
  85. Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol. 2014 May-Jun; 4(3):167-173. PMID: 24766683; PMCID: PMC4003410.
  86. Wo JY, Childs SK, Szymonifka J, Mamon HJ, Ryan DP, Blaszkowsky LS, Kwak EL, Ferrone CR, Allen JN, Zhu AX, Wolpin BM, Chan JA, Abrams TA, McCleary NJ, Fernandez-del Castillo C, Hong TS. Delaying chemoradiation until after completion of adjuvant chemotherapy for pancreatic cancer may not impact local control. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):e117-23. PMID: 24890357.
    View in: PubMed
  87. Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, Ben-Josef E, Crane CH, Goodman KA, Haddock MG, Herman JM, Hong TS, Kachnic LA, Mamon HJ, Pantarotto JR, Dawson LA. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):82-9. PMID: 24890348; PMCID: PMC4285338.
  88. Schmidt B, Look-Hong N, Maduekwe UN, Chang K, Hong TS, Kwak EL, Lauwers GY, Rattner DW, Mullen JT, Yoon SS. Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients. Ann Surg Oncol. 2013 Oct; 20(11):3512-8. PMID: 23765416.
    View in: PubMed
  89. Faris JE, Blaszkowsky LS, McDermott S, Guimaraes AR, Szymonifka J, Huynh MA, Ferrone CR, Wargo JA, Allen JN, Dias LE, Kwak EL, Lillemoe KD, Thayer SP, Murphy JE, Zhu AX, Sahani DV, Wo JY, Clark JW, Fernandez-del Castillo C, Ryan DP, Hong TS. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Oncologist. 2013; 18(5):543-8. PMID: 23657686; PMCID: PMC3662845.
  90. Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Ann Surg. 2013 Apr; 257(4):731-6. PMID: 22968073.
    View in: PubMed
  91. Hong TS. Radiotherapy for hepatocellular carcinoma with tumor vascular thrombus: ready for prime time? J Clin Oncol. 2013 May 01; 31(13):1619-20. PMID: 23547073.
    View in: PubMed
  92. Pretz JL, Wo JY, Mamon HJ, Kachnic LA, Hong TS. Chemoradiation therapy: localized esophageal, gastric, and pancreatic cancer. Surg Oncol Clin N Am. 2013 Jul; 22(3):511-24. PMID: 23622077.
    View in: PubMed
  93. Yuan Y, Andronesi OC, Bortfeld TR, Richter C, Wolf R, Guimaraes AR, Hong TS, Seco J. Feasibility study of in vivo MRI based dosimetric verification of proton end-of-range for liver cancer patients. Radiother Oncol. 2013 Mar; 106(3):378-82. PMID: 23473960.
    View in: PubMed
  94. Lee MS, Mamon HJ, Hong TS, Choi NC, Fidias PM, Kwak EL, Meyerhardt JA, Ryan DP, Bueno R, Donahue DM, Jaklitsch MT, Lanuti M, Rattner DW, Fuchs CS, Enzinger PC. Preoperative cetuximab, irinotecan, cisplatin, and radiation therapy for patients with locally advanced esophageal cancer. Oncologist. 2013; 18(3):281-7. PMID: 23429739; PMCID: PMC3607524.
  95. Hong TS, Wo JY, Kwak EL. Targeted therapies with chemoradiation in esophageal cancer: development and future directions. Semin Radiat Oncol. 2013 Jan; 23(1):31-7. PMID: 23207045.
    View in: PubMed
  96. Phillips JG, Hong TS, Ryan DP. Multidisciplinary management of early-stage rectal cancer. J Natl Compr Canc Netw. 2012 Dec 01; 10(12):1577-85. PMID: 23221792.
    View in: PubMed
  97. Hong TS. Radiation oncology whiteboard: Data and workflow manager for enhanced communication and task management. J Clin Oncol. 2012 Dec; 30(34_suppl):304. PMID: 28146901.
    View in: PubMed
  98. Chin JY, Hong TS, Ryan DP. Mitomycin in anal cancer: still the standard of care. J Clin Oncol. 2012 Dec 10; 30(35):4297-301. PMID: 23150704.
    View in: PubMed
  99. Wo JY, Hong TS, Kachnic LA. Impact of age and comorbidities on the treatment of gastrointestinal malignancies. Semin Radiat Oncol. 2012 Oct; 22(4):311-20. PMID: 22985814.
    View in: PubMed
  100. Jones WE, Thomas CR, Herman JM, Abdel-Wahab M, Azad N, Blackstock W, Das P, Goodman KA, Hong TS, Jabbour SK, Konski AA, Koong AC, Rodriguez-Bigas M, Small W, Zook J, Suh WW. ACR appropriateness criteria®??resectable rectal cancer. Radiat Oncol. 2012 Sep 24; 7:161. PMID: 23006527; PMCID: PMC3488966.
  101. Hartman RI, Chang CY, Wo JY, Eisenberg JD, Hong TS, Harisinghani MG, Gazelle GS, Pandharipande PV. Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: a decision analysis. Acad Radiol. 2013 Jan; 20(1):79-89. PMID: 22947271; PMCID: PMC3525763.
  102. Wo JY, Yoon SS, Guimaraes AR, Wolfgang J, Mamon HJ, Hong TS. Gastric lymph node contouring atlas: A tool to aid in clinical target volume definition in 3-dimensional treatment planning for gastric cancer. Pract Radiat Oncol. 2013 Jan-Mar; 3(1):e11-9. PMID: 24674268.
    View in: PubMed
  103. Elnahal SM, Shinagare AB, Szymonifka J, Hong TS, Enzinger PC, Mamon HJ. Prevalence and significance of subcentimeter hepatic lesions in patients with localized pancreatic adenocarcinoma. Pract Radiat Oncol. 2012 Oct-Dec; 2(4):e89-94. PMID: 24674191; PMCID: PMC4350367.
  104. Chen RC, Mamon HJ, Ancukiewicz M, Killoran JH, Crowley EM, Blaszkowsky LS, Wo JY, Ryan DP, Hong TS. Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 15; 83(4):e513-7. PMID: 22436781.
    View in: PubMed
  105. Arvold ND, Willett CG, Fernandez-del Castillo C, Ryan DP, Ferrone CR, Clark JW, Blaszkowsky LS, Deshpande V, Niemierko A, Allen JN, Kwak EL, Wadlow RC, Zhu AX, Warshaw AL, Hong TS. Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e337-43. PMID: 22414286.
    View in: PubMed
  106. Hong TS, Tomé WA, Harari PM. Heterogeneity in head and neck IMRT target design and clinical practice. Radiother Oncol. 2012 Apr; 103(1):92-8. PMID: 22405806; PMCID: PMC3694728.
  107. Hong TS, Clark JW, Haigis KM. Cancers of the colon and rectum: identical or fraternal twins? Cancer Discov. 2012 Feb; 2(2):117-21. PMID: 22585856.
    View in: PubMed
  108. Konski AA, Suh WW, Herman JM, Blackstock AW, Hong TS, Poggi MM, Rodriguez-Bigas M, Small W, Thomas CR, Zook J. ACR Appropriateness Criteria®-Recurrent Rectal Cancer. Gastrointest Cancer Res. 2012 Jan; 5(1):3-12. PMID: 22574231; PMCID: PMC3348710.
  109. Hong TS, Wo JY, Kwak EL. A matter of timing: is there a role for radiation in locally advanced pancreatic cancer, and if so, when? Am Soc Clin Oncol Educ Book. 2012; 238-42. PMID: 24451741.
    View in: PubMed
  110. Hallman JL, Mori S, Sharp GC, Lu HM, Hong TS, Chen GT. A four-dimensional computed tomography analysis of multiorgan abdominal motion. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):435-41. PMID: 22197238.
    View in: PubMed
  111. Knopf AC, Hong TS, Lomax A. Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics. Phys Med Biol. 2011 Nov 21; 56(22):7257-71. PMID: 22037710.
    View in: PubMed
  112. Arvold ND, Ryan DP, Niemierko A, Blaszkowsky LS, Kwak EL, Wo JY, Allen JN, Clark JW, Wadlow RC, Zhu AX, Fernandez-Del Castillo C, Hong TS. Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer. 2012 Jun 15; 118(12):3026-35. PMID: 22020923.
    View in: PubMed
  113. Skinner HD, Hong TS, Krishnan S. Charged-particle therapy for hepatocellular carcinoma. Semin Radiat Oncol. 2011 Oct; 21(4):278-86. PMID: 21939857; PMCID: PMC3230301.
  114. Alexander BM, Fernandez-Del Castillo C, Ryan DP, Kachnic LA, Hezel AF, Niemierko A, Willett CG, Kozak KR, Blaszkowsky LS, Clark JW, Warshaw AL, Hong TS. Intraductal papillary mucinous adenocarcinoma of the pancreas: clinical outcomes, prognostic factors, and the role of adjuvant therapy. Gastrointest Cancer Res. 2011 Jul; 4(4):116-21. PMID: 22368734; PMCID: PMC3283102.
  115. Wo JY, Mamon HJ, Ryan DP, Hong TS. T3N0 rectal cancer: radiation for all? Semin Radiat Oncol. 2011 Jul; 21(3):212-9. PMID: 21645866.
    View in: PubMed
  116. Russo AL, Borger DR, Ryan DP, Fan KC, Lopez H, Scialabba V, Blaszkowsky LS, Kwak EL, Clark JW, Allen JN, Wadlow RC, Zhu AX, Wang R, Dias-Santagata D, Hong TS, Iafrate AJ. Mutational analysis and clinical correlation of 185 consecutive metastatic colorectal patients: Similarities and differences between colon and rectal patients. J Clin Oncol. 2011 May 20; 29(15_suppl):3536. PMID: 28020316.
    View in: PubMed
  117. Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Berger D, Fernandez-Del Castillo C, Zhu AX. A prospective study of capecitabine (cape), oxaliplatin (ox), bevacizumab (B), and radiation therapy (RT) (CAPOX-B RT) in patients with locally advanced or R1 biliary cancers: High risk of liver failure with extended hepatectomy. J Clin Oncol. 2011 May 20; 29(15_suppl):e14593. PMID: 28020501.
    View in: PubMed
  118. Wo JY, Ryan DP, Kulke MH, Hong TS. Radiation recall associated with insulin growth factor 1R antibody. Pract Radiat Oncol. 2011 Jul-Sep; 1(3):208-11. PMID: 24673952.
    View in: PubMed
  119. Blaszkowsky LS, Cusack JC, Hong TS, Chung DC, Blake MA, Lennerz JK. Case records of the Massachusetts General Hospital. Case 13-2011. A 49-year-old man with adenocarcinoma of the rectum. N Engl J Med. 2011 Apr 28; 364(17):1658-68. PMID: 21524217.
    View in: PubMed
  120. Margalit DN, Mamon HJ, Ancukiewicz M, Kobayashi W, Ryan DP, Blaszkowsky LS, Clark J, Willett CG, Hong TS. Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and older. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):e735-41. PMID: 21377289.
    View in: PubMed
  121. Craft DL, Hong TS, Shih HA, Bortfeld TR. Improved planning time and plan quality through multicriteria optimization for intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):e83-90. PMID: 21300448; PMCID: PMC3202037.
  122. Schoenfeld JD, Mamon HJ, Blaszkowsky LS, Enzinger PC, Wo JY, Allen JN, Wadlow RC, Ryan DP, Hong TS. Gastric adenocarcinoma treated with radiation with or without epirubicin-based chemotherapy: Evaluation of radiation-induced liver disease. J Clin Oncol. 2011 Feb; 29(4_suppl):110. PMID: 27985444.
    View in: PubMed
  123. Chun S, Lee M, Jeon E, An H, Hong T, You Y, Kim D, Lee I. Comparison of the efficacy of gemcitabine with capecitabine and gemcitabine with erlotinib combination chemotherapy in recurrent or advanced pancreatic cancer as first-line treatment: Single-center experience. J Clin Oncol. 2011 Feb; 29(4_suppl):329. PMID: 27985890.
    View in: PubMed
  124. Hong TS, Mamon H. Short-course versus standard chemoradiation in T3 rectal cancer. Oncologist. 2011; 16(5):717-21. PMID: 21586661; PMCID: PMC3228203.
  125. Adkison JB, McHaffie DR, Bentzen SM, Patel RR, Khuntia D, Petereit DG, Hong TS, Tomé W, Ritter MA. Phase I trial of pelvic nodal dose escalation with hypofractionated IMRT for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):184-90. PMID: 21163590; PMCID: PMC3347884.
  126. Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, Willins JD, Ryan DP, Hong TS. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):153-8. PMID: 21095071.
    View in: PubMed
  127. Mak RH, McCarthy EP, Das P, Hong TS, Mamon HJ, Hoffman KE. Adoption of preoperative radiation therapy for rectal cancer from 2000 to 2006: a Surveillance, Epidemiology, and End Results Patterns-of-Care Study. Int J Radiat Oncol Biol Phys. 2011 Jul 15; 80(4):978-84. PMID: 20961695.
    View in: PubMed
  128. Klos CL, Shellito PC, Rattner DW, Hodin RA, Cusack JC, Bordeianou L, Sylla P, Hong TS, Blaszkowsky L, Ryan DP, Lauwers GY, Chang Y, Berger DL. The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg. 2010 Oct; 200(4):440-5. PMID: 20887837.
    View in: PubMed
  129. Arvold ND, Niemierko A, Mamon HJ, Fernandez-del Castillo C, Hong TS. Pancreatic cancer tumor size on CT scan versus pathologic specimen: implications for radiation treatment planning. Int J Radiat Oncol Biol Phys. 2011 Aug 01; 80(5):1383-90. PMID: 20708856; PMCID: PMC4362517.
  130. Engelsman M, DeLaney TF, Hong TS. Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions. Int J Radiat Oncol Biol Phys. 2011 Feb 01; 79(2):616-22. PMID: 20675067; PMCID: PMC2972377.
  131. Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, Adams J, Yeap B, Winrich B, DeLaney TF, Fernandez-Del Castillo C. Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):151-7. PMID: 20421151.
    View in: PubMed
  132. Chen RC, Mamon HJ, Chen YH, Gelman RS, Suh WW, Talcott JA, Clark JW, Hong TS. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer. 2010 Apr 15; 116(8):1879-86. PMID: 20166212.
    View in: PubMed
  133. Zhu AX, Hong TS, Hezel AF, Kooby DA. Current management of gallbladder carcinoma. Oncologist. 2010; 15(2):168-81. PMID: 20147507; PMCID: PMC3227945.
  134. Miyamoto DT, Mamon HJ, Ryan DP, Willett CG, Ancukiewicz M, Kobayashi WK, Blaszkowsky L, Fernandez-del Castillo C, Hong TS. Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1171-7. PMID: 19800182.
    View in: PubMed
  135. Mak RH, Mamon HJ, Ryan DP, Miyamoto DT, Ancukiewicz M, Kobayashi WK, Willett CG, Choi NC, Blaszkowsky LS, Hong TS. Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older. Dis Esophagus. 2010 May; 23(4):316-23. PMID: 19788436.
    View in: PubMed
  136. Hattangadi JA, Hong TS, Yeap BY, Mamon HJ. Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma. Cancer. 2009 Aug 15; 115(16):3640-50. PMID: 19514088; PMCID: PMC3808178.
  137. Kwak EL, Hong TS, Berger DL, Forcione DG, Uppot RN, Lauwers GY. Case records of the Massachusetts General Hospital. Case 19-2009. A 63-year-old woman with carcinoma of the gastroesophageal junction. N Engl J Med. 2009 Jun 18; 360(25):2656-64. PMID: 19535805.
    View in: PubMed
  138. Blaszkowsky LS, Hong TS, Zhu AX, Kwak EL, Mamon HJ, Shellito PC, Cusack JC, Berger D, Horgan K, Ryan DP. A phase I/II study of bevacizumab (beva), erlotinib (erl), and 5-fluorouracil (5-FU) with concurrent external beam radiation therapy (RT) in locally advanced rectal cancer (LARC). J Clin Oncol. 2009 May 20; 27(15_suppl):4106. PMID: 27961180.
    View in: PubMed
  139. Hong T, Ryan DP, Blaszkowsky LS, Mamon HJ, Mino-Kenudson M, Adams J, Yeap B, Winrich B, DeLaney TF, Fernandez-Del Castillo C. Phase I study of preoperative (pre-op) short course chemoradiation (CRT) with proton beam therapy (PBT) and capecitabine (cape) for resectable pancreatic ductal adenocarcinoma (PDAC) of the head. J Clin Oncol. 2009 May 20; 27(15_suppl):e15536. PMID: 27962312.
    View in: PubMed
  140. Patel AA, Wolfgang JA, Niemierko A, Hong TS, Yock T, Choi NC. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys. 2009 May 01; 74(1):290-6. PMID: 19362248.
    View in: PubMed
  141. Hong TS; Kachnic LA. Pretreatment planning in radiation therapy of the esophagus. Esophageal Cancer: Principles and Practice. 2009.
  142. Myerson RJ, Garofalo MC, El Naqa I, Abrams RA, Apte A, Bosch WR, Das P, Gunderson LL, Hong TS, Kim JJ, Willett CG, Kachnic LA. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys. 2009 Jul 01; 74(3):824-30. PMID: 19117696; PMCID: PMC2709288.
  143. Hong TS, Killoran JH, Mamede M, Mamon HJ. Impact of manual and automated interpretation of fused PET/CT data on esophageal target definitions in radiation planning. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1612-8. PMID: 19028285.
    View in: PubMed
  144. Hong TS, Craft DL, Carlsson F, Bortfeld TR. Multicriteria optimization in intensity-modulated radiation therapy treatment planning for locally advanced cancer of the pancreatic head. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):1208-14. PMID: 18954714; PMCID: PMC2614315.
  145. Balboni TA, Ng A, Block SD, Balboni MJ, Kachnic LA, Stevenson MA, Hong TS, Trice ED, Wright AA, Prigerson HG. Needs and perceptions of spiritual care among advanced cancer patients. J Clin Oncol. 2008 May 20; 26(15_suppl):9560. PMID: 27948176.
    View in: PubMed
  146. Kozak KR, Hong TS, Sluss PM, Lewandrowski EL, Aleryani SL, Macdonald SM, Choi NC, Yock TI. Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer. 2008 Dec; 62(3):351-5. PMID: 18462828.
    View in: PubMed
  147. Hoffman KE, Hong TS, Zietman AL, Russell AH. External beam radiation treatment for rectal cancer is associated with a decrease in subsequent prostate cancer diagnosis. Cancer. 2008 Feb 15; 112(4):943-9. PMID: 18098220.
    View in: PubMed
  148. Kachnic LA, Hong TS, Ryan DP. Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease. J Clin Oncol. 2008 Jan 20; 26(3):350-1. PMID: 18202407.
    View in: PubMed
  149. Alexander, BM ; Hong, TS. Rectal Cancer. Harrison's Manual of Oncology. 2008.
  150. Hong TS, Welsh JS, Ritter MA, Harari PM, Jaradat H, Mackie TR, Mehta MP. Megavoltage computed tomography: an emerging tool for image-guided radiotherapy. Am J Clin Oncol. 2007 Dec; 30(6):617-23. PMID: 18091057.
    View in: PubMed
  151. Kozak KR, Kachnic LA, Adams J, Crowley EM, Alexander BM, Mamon HJ, Fernandez-Del Castillo C, Ryan DP, DeLaney TF, Hong TS. Dosimetric feasibility of hypofractionated proton radiotherapy for neoadjuvant pancreatic cancer treatment. Int J Radiat Oncol Biol Phys. 2007 Aug 01; 68(5):1557-66. PMID: 17544599.
    View in: PubMed
  152. Hong TS, Kachnic LA. Preoperative chemoradiotherapy in the management of localized rectal cancer: the new standard. Gastrointest Cancer Res. 2007 Mar; 1(2):49-56. PMID: 19262719; PMCID: PMC2632869.
  153. Hong TS, Crowley EM, Killoran J, Mamon HJ. Considerations in treatment planning for esophageal cancer. Semin Radiat Oncol. 2007 Jan; 17(1):53-61. PMID: 17185198.
    View in: PubMed
  154. Sharp GC, Lu HM, Trofimov A, Tang X, Jiang SB, Turcotte J, Gierga DP, Chen GT, Hong TS. Assessing residual motion for gated proton-beam radiotherapy. J Radiat Res. 2007; 48 Suppl A:A55-9. PMID: 17513900.
    View in: PubMed
  155. Hoffman KE, Hong TS, Zietman AL, Russell AH. Pelvic irradiation for rectal cancer is associated with a decreased risk of subsequent clinically detected prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2232.
  156. Lu H, Safai S, Schneider R, Adams J,Chen Y, Sharp G, Brett B, D. Kirsch, Hong T, Delaney T. Respiratory-Gated Proton Therapy Treatment. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2734.
  157. Patel AA, Wolfgang JA, Niemierko A, Hong TS, Yock T, Choi NC. Implictaions of respiratory motion as mesured by 4D CT for radiation treatment planning of esophageal tumors. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2715.
  158. Kachnic L, Tsai HK, Willins J, Kung JH, Feng JK, Shih HA, Hong TS. Dose-painted intensity modulated radiation therapy for anal cancer: dosimetric comparison and acute toxicity. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2126.
  159. Alexander BM, Kachnic LA, Willett CG, Fernandez-del Castillo C, Warshaw AL, Blaszkowsky LS, Ryan DP, Clark JW, Niemierko A, Hong TS. Adjuvant therapy for invasive intraductal paopillary mucinous neoplasms of the pancreas. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2099.
  160. Chen RC, Fidias P, Yock TI, Niemierko A, Ancukiewicz M, Hong TS, Wolfgang JA, Gurubhagavatula S, Choi NC. Treatment-related pneumonitis after concurrent cisplatin/etoposide and thoracic radiation therapy in lung cancer. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2490.
  161. Hong TS, Crowley EM, Tsai HK, Blake MA, Napolitano BN, Kachnic LA. A 3-dimensional CT-based atlas for radiation planning in gastric cancer: Target delineation and implications for treatment planning. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 SI):A2150.
  162. Crowley EM, Kachnic LA, Mamon HJ, Ritter MA, Niemierko A, Yock TI, Choi NC, Hong TS. Optimizing the cardiac and pulmonary dose in treatment planning for distal esophageal cancer: Does IMRT always produce the best plan?. International Journal of Radiation Oncology*Biology*Physics. 2006; 66(3 S1):A2128.
  163. Favaro JP, Petros W, Hong T, Fernando N, Bendell JC, Gockerman JP, George DJ, Williams-Truax R, Nixon A, Yu D, Hurwitz H. Phase I dose escalation, pharmacokinetic, and biomarker study of imatinib mesylate plus capecitabine in advanced solid tumor malignancies. J Clin Oncol. 2006 Jun 20; 24(18_suppl):3093. PMID: 27955143.
    View in: PubMed
  164. Connor NP, Cohen SB, Kammer RE, Sullivan PA, Brewer KA, Hong TS, Chappell RJ, Harari PM. Impact of conventional radiotherapy on health-related quality of life and critical functions of the head and neck. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1051-62. PMID: 16682129.
    View in: PubMed
  165. Hong TS, Blake MA, Tsai H, Kachnic LA. A 3-dimensional CT-based atlas for radiation planning in gastric cancer. 2006 Gastrointestinal Cancers Symposium. 2006; 103.
  166. Tsai HK, Hong TS, Willins J, Kung JH, Feng JK, Shih HA, Kachnic LA. Dosimetric comparison of dose-painted intensity modulated radiation therapy versus conventional radiation therapy for anal cancer. 2006 Gastrointestinal Cancers Symposium. 2006; 255.
  167. Hong TS, Tomé WA, Jaradat H, Raisbeck BM, Ritter MA. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy. Acta Oncol. 2006; 45(6):717-27. PMID: 16938815.
    View in: PubMed
  168. Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Zeltzer PM. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study. Pediatr Blood Cancer. 2005 Oct 15; 45(5):676-82. PMID: 16007595.
    View in: PubMed
  169. Bentzen SM, Hong TS, Tome WA, Harari PM. . International Survey of 4D Dose-Prescriptions in IMRT for Head and Neck Squamous Cell Carcinoma: A Modeled Comparison of Expected Outcome. International Journal of Radiation Oncology*Biology*Physics. 2005; 63(S1):S75.
  170. Tome WA, Hong TS, Gentry LR, Manon R, Shah H, Harari PM. . Integrity of Parotid Gland Delineation for H&N IMRT: What Are We Sparing?. International Journal of Radiation Oncology*Biology*Physics. 2005; 63(S1):S130.
  171. Hong TS, Tome WA, Jaradat H, Raisbeck BM, Ritter MA. Pelvic Nodal Dose Escalation with Prostate Hypofractionation Using Conformal Avoidance Defined (H-CAD) Intensity Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2005; 63(S1):S61.
  172. Hong TS, Kriesel KJ, Hartig GK, Harari PM. Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis. Head Neck. 2005 Oct; 27(10):851-6. PMID: 16114004.
    View in: PubMed
  173. Hong TS, Tomé WA, Harari PM. . Intensity modulated radiation therapy (IMRT) in the management of head and neck cancer. Current Clinical Oncology: Squamous Cell Head and Neck Cancer. Adelstein DJ (Ed.). 2005; 115-124.
  174. Hong TS, Ritter MA, Tomé WA, Harari PM. Intensity-modulated radiation therapy: emerging cancer treatment technology. Br J Cancer. 2005 May 23; 92(10):1819-24. PMID: 15856036; PMCID: PMC2361760.
  175. Hong TS, Tomé WA, Harari PM. Intensity-modulated radiation therapy in the management of head and neck cancer. Curr Opin Oncol. 2005 May; 17(3):231-5. PMID: 15818166.
    View in: PubMed
  176. Hong TS, Tomé WA, Chappell RJ, Chinnaiyan P, Mehta MP, Harari PM. The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005 Mar 01; 61(3):779-88. PMID: 15708257.
    View in: PubMed
  177. Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study. Int J Radiat Oncol Biol Phys. 2004 Sep 01; 60(1):204-13. PMID: 15337557.
    View in: PubMed
  178. Hong TS, Tome WA, Chappell RJ, Harari PM. . Variations in target delineation for head and neck IMRT: An international multi-institutional study. International Journal of Radiation Oncology*Biology*Physics. 2004; 60(1):S157-S158.
  179. Hong TS, Song S, Tomé WA, Harari PM. Emerging approaches in the management of head and neck cancer: Intensity-modulated radiation therapy. American Society of Clinical Oncology: Educational Book 2004 (Ed. Perry MC). 2004; 314-318.
  180. Bai JZ, Ban Y, Bian JG, Cai X, Chang JF, Chen HF, Chen HS, Chen J, Chen J, Chen JC, Chen YB, Chi SP, Chu YP, Cui XZ, Dai YM, Dai YS, Dong LY, Du SX, Du ZZ, Dunwoodie W, Fang J, Fang SS, Fu CD, Fu HY, Fu LP, Gao CS, Gao ML, Gao YN, Gong MY, Gong WX, Gu SD, Guo YN, Guo YQ, Guo ZJ, Han SW, Harris FA, He J, He KL, He M, He X, Heng YK, Hong T, Hu HM, Hu T, Huang GS, Huang L, Huang XP, Izen JM, Ji XB, Jiang CH, Jiang XS, Jin DP, Jin S, Jin Y, Jones BD, Ke ZJ, Kong D, Lai YF, Li F, Li G, Li HH, Li J, Li JC, Li K, Li QJ, Li RB, Li RY, Li W, Li WG, Li XQ, Li XS, Liu CF, Liu CX, Liu F, Liu F, Liu HM, Liu JB, Liu JP, Liu RG, Liu Y, Liu ZA, Liu ZX, Lou XC, Lu GR, Lu F, Lu HJ, Lu JG, Lu ZJ, Luo XL, Ma EC, Ma FC, Ma JM, Malchow R, Mao ZP, Meng XC, Mo XH, Nie J, Nie ZD, Olsen SL, Paluselli D, Peng HP, Qi ND, Qian CD, Qiu JF, Rong G, Shen DL, Shen H, Shen XY, Sheng HY, Shi F, Song LW, Sun HS, Sun SS, Sun YZ, Sun ZJ, Tang SQ, Tang X, Tian D, Tian YR, Toki W, Tong GL, Varner GS, Wang J, Wang JZ, Wang L, Wang LS, Wang M, Wang M, Wang P, Wang PL, Wang WF, Wang YF, Wang Z, Wang Z, Wang Z, Wang ZY, Wei CL, Wu N, Xia XM, Xie XX, Xu GF, Xu Y, Xue ST, Yan ML, Yan WB, Yang GA, Yang HX, Yang J, Yang SD, Ye MH, Ye YX, Ying J, Yu CS, Yu GW, Yuan CZ, Yuan JM, Yuan Y, Yue Q, Zang SL, Zeng Y, Zhang BX, Zhang BY, Zhang CC, Zhang DH, Zhang HY, Zhang J, Zhang JM, Zhang JW, Zhang LS, Zhang QJ, Zhang SQ, Zhang XY, Zhang YJ, Zhang Y, Zhang YY, Zhang ZP, Zhao DX, Zhao J, Zhao JW, Zhao PP, Zhao WR, Zhao YB, Zhao ZG, Zheng JP, Zheng LS, Zheng ZP, Zhong XC, Zhou BQ, Zhou GM, Zhou L, Zhou NF, Zhu KJ, Zhu QM, Zhu Y, Zhu YC, Zhu YS, Zhu ZA, Zhuang BA, Zou BS. Observation of a near-threshold enhancement in the pp mass spectrum from radiative J/psi-->gammapp decays. Phys Rev Lett. 2003 Jul 11; 91(2):022001. PMID: 12906471.
    View in: PubMed
  181. Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol. 2002 Dec; 25(6):606-11. PMID: 12478010.
    View in: PubMed
  182. Bradley KA, Hong TS, Tome WA, Hayes L, Resnick D, Mehta MP. . LINAC-based radiosurgery in the treatment of trigeminal neuralgia: a preliminary report. International Journal of Radiation Oncology*Biology*Physics. 2002; 54(2):303-304.
  183. Bai JZ, Ban Y, Bian JG, Chen AD, Chen HF, Chen HS, Chen JC, Chen XD, Chen YB, Cheng BS, Chi SP, Chu YP, Choi JB, Cui XZ, Dai YS, Dong LY, Du ZZ, Dunwoodie W, Fu HY, Fu LP, Gao CS, Gu SD, Guo YN, Guo ZJ, Han SW, Han Y, Harris FA, He J, He JT, He KL, He M, He X, Hong T, Heng YK, Hu GY, Hu HM, Hu QH, Hu T, Huang GS, Huang XP, Huang YZ, Izen JM, Ji XB, Jiang CH, Jin Y, Jones BD, Kang JS, Ke ZJ, Kim HJ, Kim SK, Kim TY, Kong D, Lai YF, Li D, Li HB, Li HH, Li J, Li JC, Li PQ, Li QJ, Li RY, Li W, Li WG, Li XN, Li XQ, Liu B, Liu F, Liu F, Liu HM, Liu J, Liu JP, Liu TR, Liu RG, Liu Y, Liu ZX, Lou XC, Lu GR, Lu F, Lu JG, Lu ZJ, Luo XL, Ma EC, Ma JM, Malchow R, Mao HS, Mao ZP, Meng XC, Mo XH, Nie J, Nie ZD, Olsen SL, Paluselli D, Park H, Qi ND, Qi XR, Qian CD, Qiu JF, Que YK, Rong G, Shao YY, Shen BW, Shen DL, Shen H, Shen XY, Sheng HY, Shi F, Shi HZ, Song XF, Suh JY, Sun HS, Sun LF, Sun YZ, Tang SQ, Toki W, Tong GL, Varner GS, Wang J, Wang JZ, Wang L, Wang LS, Wang P, Wang PL, Wang SM, Wang YY, Wang ZY, Wei CL, Wu N, Xi DM, Xia XM, Xie XX, Xu GF, Xu Y, Xue ST, Yan WB, Yan WG, Yang CM, Yang CY, Yang GA, Yang HX, Yang W, Yang XF, Ye MH, Ye SW, Ye YX, Yu CS, Yu CX, Yu GW, Yuan Y, Zhang BY, Zhang C, Zhang CC, Zhang DH, Zhang HL, Zhang HY, Zhang J, Zhang JW, Zhang L, Zhang LS, Zhang P, Zhang QJ, Zhang SQ, Zhang XY, Zhang YY, Zhang ZP, Zhao DX, Zhao HW, Zhao J, Zhao JW, Zhao M, Zhao PP, Zhao WR, Zhao YB, Zhao ZG, Zheng JP, Zheng LS, Zheng ZP, Zhou BQ, Zhou GM, Zhou L, Zhu KJ, Zhu QM, Zhu YC, Zhu YS, Zhu ZA, Zhuang BA, Zou BS. Measurements of the cross section for e(+)e(-) --> hadrons at center-of-mass energies from 2 to 5 GeV. Phys Rev Lett. 2002 Mar 11; 88(10):101802. PMID: 11909342.
    View in: PubMed
  184. Uchida S, Shimada Y, Watanabe G, Li ZG, Hong T, Miyake M, Imamura M. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer. 1999 Mar; 79(7-8):1168-73. PMID: 10098753; PMCID: PMC2362236.
  185. Jin C, Jiang X, Hong T, Wang Y, Xu T, Zhang D. [Pharmacological studies of luohanguo yanhou tablet]. Zhong Yao Cai. 1997 Nov; 20(11):574-7. PMID: 12572514.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Hong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_